IPO

Walpar Nutritions Limited IPO

NSE SME

Listed On: Jul 15, 2021 at ₹ 54.1

₹ 220000 /4000 Shares
*Min Investment

Check Allotment

30 Jun, 2021

Open Date

05 Jul, 2021

Close Date

12 Jul, 2021

Allotment Date

15 Jul, 2021

Listing Date
IPO Issue Details
  • Issue Price ₹55 per equity share
  • Face Value ₹10 Per Equity Share 
  • Issue Price 1,200,000 Eq Shares of ₹10 (aggregating up to ₹6.60 Cr)
  • Listing at NSE SME
  • List Price 54.1
  • Listing Date 2021-07-15
  • Lead Manager Beeline Broking Ltd
  • Registrar Skyline Financial Services Private Ltd
IPO Details
  • Retail Portion N/A
IPO Documents
IPO Details


Walpar Nutritions Limited IPO is an SME IPO, priced at ₹55 per equity share. The equity shares have a face value of ₹10 Per Equity Share  each and will be listed on the NSE SME platform.

The IPO bidding window is open from Jun 30, 2021 to Jul 5, 2021. The allotment is expected to be finalized on Jul 12, 2021, and the tentative listing date is Jul 15, 2021.


The registrar of the IPO is Skyline Financial Services Private Ltd, and

Read More
IPO Subscription Analysis And Details
Retail
17.94x
Total
9.48x
As onQIB / NIIRetailTotal
Shares Offered / Reserved570,000570,0001,140,000
Day 1 30-06-21 05:00 PM
0.03 x0.67 x0.35 x
Day 2 01-07-21 05:00 PM
0.52 x4.48 x2.50 x
Day 3 02-07-21 05:00 PM
0.54 x8.34 x4.44 x
Day 4 05-07-21 05:00 PM
1.01 x17.94 x9.48 x
Valuations
Earnings Per Share (EPS) ₹N/A/-
P/E Ratio N/A
RoNW N/A%
Net Asset Value (NAV) - Post Issue ₹N/A/-
Company Financials
In Crs.
In Cr.
31-Mar-2031-Mar-1931-Mar-18
Assets13.179.183.90
Revenue16.7112.826.44
Profit After Tax0.120.060.01
About Company

Incorporated in 2009, Walpar Nutritions manufactures different types of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness, and food supplement products. It has developed 100+ formulations and 1000 brands under different segments i.e. Orthopaedics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Gynaecology, Neuro, Gastro-Intestinal, and sports nutrition. It further manufactures tablets, capsules, Ointments, creams, lotions, gels and sachet, powders, liquid orals, etc.

The company has a manufacturing facility in Gandhinagar with an installed manufacturing capacity of 23 lakhs tablet/month, 12.50 lakhs capsules/month, 1.50 lakhs oral liquids/month, and 2 lakhs sachets/month.

Read More
- Promoter(s)

Mr. Kalpesh Pravinchandra Ladhawala

Mr. Tanmay Kumar Ashwinbhai

Mrs. Sejal Kalpesh Ladhawala

Pre Issue Share Holding : 96.53%

Post Issue Share Holding : 71.02%

IPO - Issue Objectives
1

To invest in subsidiaries.

2

Meet working capital requirements.

3

Meet general corporate purposes.

4

Meet issue expenditures.